Two scientists just got a major award for turning weird physics into useful tools. Charles Bennett and Gilles Brassard didn’t just study quantum quirks—they turned them into a way to send messages that even hackers can’t crack. Their work in the late 1980s showed how particles could carry informatio
Dravet syndrome is a tough type of epilepsy that does not get better with one drug. Doctors often have to give patients three or more seizure medicines at the same time. The mix of drugs is very complicated because it includes special medicines for Dravet (like stiripentol, cannabidiol, and fenflura
A new study followed 217 people who had never taken pain pills before and were getting spine surgery between August 2023 and December 2024. The researchers divided the patients into groups based on how the surgery was done: a big open cut, a small tubular approach, or a very tiny endoscopic method.
The World Baseball Classic ended with a 3‑2 defeat for Team USA, and the loss highlighted how national pride can sometimes outweigh skill on the field. Instead of focusing on the game itself, the U. S. squad turned every play into a patriotic display: players saluted after hits, wore shirts with
In a recent study, nine health, social and education workers were asked about their new knowledge of trauma‑informed care (TIC) after attending a training session. The researchers used a well‑known behavior change model to analyse the interviews, looking at what people could do, had the chance to do
The Federal Reserve is likely to leave interest rates unchanged, even as oil prices jump past $100 a barrel. This decision comes after years of political pressure on the Fed, with some politicians calling for lower rates and even threatening to replace the chair. In recent legal battles, a jud
Sen. Markwayne Mullin, the Republican chosen by former President Trump to head the Department of Homeland Security, had a rocky confirmation hearing that highlighted concerns about his temperament and past foreign trips. The meeting was heated from the start, with Senate Homeland Security chair Rand
Millions of people use GLP‑1 drugs like Ozempic or Wegovy to lose weight. They often ask: what will happen once the injections end? Older clinical trials said people would gain back much of the weight quickly. These studies were very controlled and did not show what happens in everyday life
A new study shows that the heart protection you get from GLP‑1 medicines fades quickly once you stop taking them. Researchers examined records of more than 333, 000 people with type‑2 diabetes who were treated through the Veterans Health Administration. Those on GLP‑1 drugs, such as semaglutide (Oze
The number of young people in their late teens and early twenties who feel depressed or anxious is climbing fast. At the same time, more of them are spending hours on social media sites. Scientists do not yet know whether these platforms help or hurt their mental well‑being, leaving a big gap
